报告题目：Synthetic Biology: new tools for an industry at an inflection point
报 告 人：John Cumbers，SynBioBeta创始人
报告人简介：John Cumbers has a strong background in the synthetic biology industry as founder of SynBioBeta, a global activity hub and community of entrepreneurs, thought-leaders and investors. He has earned several degrees, including a PhD in molecular biology from Brown University as well as a masters degree in bioinformatics from the University of Edinburgh in Scotland and an undergraduate degree in computer science from the University of Hull in England. John is passionate about education and on the use and adoption of biological technologies. He has received multiple awards and grants from NASA and the National Academy of Sciences for his work in the field. John has been involved in multiple start-ups producing food for space and using microbes to extract lunar and martian resources. He worked at NASA for seven years working on the issues of resource utilization, extremophiles and sustainable technologies. He was instrumental in starting NASA’s program in synthetic biology and most recently, the lead for planetary sustainability at the NASA Space Portal. A super connector, community builder and consultant, John has devoted himself to helping those around him improve themselves and gain the resources that they need to break through scientific boundaries and succeed.
报告摘要：Since the popularization of the term ‘synthetic biology’ over a decade ago, a new community of biological engineers has emerged on to the scene. Thousands of practitioners,students, and entrepreneurs have joined the movement to ‘make biology easier to engineer’ and as a result, both the field and the industry has developed at a rapid pace worldwide.In 2015, over twenty five companies including Twist Bioscience, Zymergen, Ginkgo Bioworks and Bolt Threads have collectively raised over $722 million in funding to scale and propel their tools, platforms and products to market. In this most recent wave, some of Silicon Valley’s most prestigious tech investors such as Eric Schmidt, Sam Altman, Paul Graham, Yuri Milner, Jerry Yang and Max Levchin have made significant investments betting on what they think will be the next industrial revolution: the industrialization of biology.John Cumbers has been in the field of synthetic biology for over 10 years working in academia,government, startups and industry. In this talk, he will review the history of the field starting from an academic outreach pursuit to what is now a fledgling industry. He will contend that the latest wave of investment in the field is a positive sign and that the industry is now at an inflection. He will drive home that the fruits from academia coupled with new VC money create the perfect storm for this disruptive technology to unseat incumbents. Specifically, in markets ranging from pharma, biomaterials, chemicals, fuel and food which will allow for the replacing of fossil fuels with more sustainable feedstocks and seeing widespread adoption along the way.